MEDIFAST INC (MED)

Consumer · NYQ

$11.52-1.62% today

Price as at 1 Oct 2026, 01:24 UTC. Quotes are delayed.

Fundamentals

Revenue growth (YoY)-34.3%
Profit margin-5.8%
Return on equity-9.8%
52-week range$9.22 to $14.15

Valuation and ratings

Analyst target (mean)$12.00
Analyst range$12.00 to $12.00
Analysts with price targets1
Consensus viewhold
Moat score35/100
Overall rating39/100, low quality

MEDIFAST INC trades at $11.52. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.

Our moat model scores it 35 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

MED dividend history

Most recent payment$1.65, ex 18 Sept 2023
5-year growth (p.a.)+17.7%
Consecutive years paid9

Dividends per share by year

YearTotal per sharePayments
2023$4.953
2022$6.564
2021$5.684
2020$4.524
2019$3.384
2018$2.194
2017$1.444
2016$1.074
2015$0.2501

Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.

MED earnings and analyst estimates

EPS estimate, next year-$0.60
Expected EPS growth+67.6%
Expected revenue growth-8.5%

Recommendation mix, 1 published rating

0 buy1 hold0 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About MEDIFAST INC

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Industry: Personal ServicesEmployees: 380HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Super investor ownership

9 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in MED

Trades in MED disclosed by members of Congress and executive-branch officials, latest first:

  • Donna Shalala · HouseSell · $1,001 - $15,000 · traded 24 Jun 2019 · disclosed 27 Apr 2020
  • Donna Shalala · HouseBuy · $1,001 - $15,000 · traded 30 Apr 2019 · disclosed 27 Apr 2020

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

MED peers

The largest companies in the same industry (Personal Services), then in the same sector.

Every consumer company we cover is on the Consumer hub.

Common questions

Which funds own MED?

9 of the institutions we track reported a position in MED in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.

Where does SteadyShares get its MED data?

Fundamentals for MED come from company filings and exchange data, as listed on NYQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 01:24 UTC and is delayed. Our data quality score for this company is 79/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for MED, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.